FIELD: medicine.
SUBSTANCE: the present innovation deals with applying triprolidine for providing the chance for a patient to get up in the reconstructed state and method for treating the mentioned patient with triprolidine. Moreover, The innovation reveals triprolidine application as an active ingredient for obtaining the composition for treating sleep disorders. Moreover, it is possible to treat a patient's sleep in case of sleep disorders and this method deals with introducing an efficient dosage of triprolidine for such a patient as an active component. Triprolidine should be introduced before the sleep, preferably orally and mostly preferably in the form of a tablet that contains up to 20 mg active component. Except this, triprolidine is being an efficient preparation in providing the chance for a patient to sleep more calmly.
EFFECT: higher efficiency.
34 cl, 7 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF MEDICATION FOR TREATING SLEEP DISTURBANCES | 2004 |
|
RU2354374C2 |
APPLICATION OF TRIPROLIDINE TO ENSURE VIVACITY IN AWAKENING | 2004 |
|
RU2372915C2 |
TREATING SLEEP DISTURBANCES | 2008 |
|
RU2483733C2 |
METHOD OF TREATING INSOMNIA | 2002 |
|
RU2560840C2 |
MELATONIN AGONIST THERAPY | 2007 |
|
RU2488392C2 |
COMPOSITIONS AND METHODS FOR TREATING INSOMNIA | 2015 |
|
RU2703297C2 |
CAFFEINE-CONTAINING COMPOSITIONS OF PROLONGED ACTION | 1995 |
|
RU2144353C1 |
PROBIOTIC BACTERIAL STRAIN FOR OBTAINING NUTRIENT COMPOSITION IMPROVING SLEEP NATURE | 2009 |
|
RU2642301C9 |
NOURISHING COMPOSITION, INCLUDING PROBIOTICS AND IMPROVING SLEEP PATTERN | 2009 |
|
RU2517616C2 |
METHOD FOR TREATING AND PREVENTING BENZODIAZEPINE GROUP MEDICAMENT ADDICTION OR INSENSITIVITY OR TOLERATION SYMPTOMS | 1996 |
|
RU2182001C2 |
Authors
Dates
2008-03-27—Published
2002-12-02—Filed